BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23106225)

  • 1. Melanoma epidemiology, prognosis and trends in Latvia.
    Azarjana K; Ozola A; Ruklisa D; Cema I; Rivosh A; Azaryan A; Pjanova D
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1352-9. PubMed ID: 23106225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and epidemiological characteristics of cutaneous and mucosal head and neck melanoma.
    Berzina A; Azarjana K; Cema I; Pjanova D; Rivosh A
    Stomatologija; 2011; 13(2):49-54. PubMed ID: 21822045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and prognostic variables of cutaneous melanoma observed between 1995 and 2000 at Istituto Dermopatico Dell'Immacolata (IDI-IRCCS), Rome, Italy.
    Fortes C; Mastroeni S; Sera F; Concolino F; Abeni D; Melchi F; Forastiere F; Pasquini P
    Eur J Cancer Prev; 2006 Apr; 15(2):171-7. PubMed ID: 16523015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999).
    Kittler H; Binder M; Wolff K; Pehamberger H
    Wien Klin Wochenschr; 2001 Apr; 113(9):321-7. PubMed ID: 11388077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
    Golger A; Young DS; Ghazarian D; Neligan PC
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dubreuilh melanoma: and epidemiologic and prognostic study].
    Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
    Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in melanoma epidemiology suggest three different types of melanoma.
    Lipsker D; Engel F; Cribier B; Velten M; Hedelin G
    Br J Dermatol; 2007 Aug; 157(2):338-43. PubMed ID: 17596175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008.
    Shaikh WR; Weinstock MA; Halpern AC; Oliveria SA; Geller AC; Dusza SW
    Cancer Epidemiol; 2013 Feb; 37(1):64-70. PubMed ID: 22995853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of thick melanomas in the United States: beware of the nodular subtype.
    Demierre MF; Chung C; Miller DR; Geller AC
    Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B; Leiter U; Garbe C
    Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
    Crocetti E; Carli P
    Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK; Buettner PG; Leiter U; Garbe C;
    J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
    Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
    Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing biology of cutaneous melanoma.
    Peric B; Zgajnar J; Besic N; Hocevar M
    Melanoma Res; 2008 Jun; 18(3):225-9. PubMed ID: 18477898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).
    Metelitsa AI; Dover DC; Smylie M; de Gara CJ; Lauzon GJ
    J Am Acad Dermatol; 2010 Feb; 62(2):227-32. PubMed ID: 20018405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991.
    Cavalieri R; Macchini V; Mostaccioli S; Sonego G; Ferranti G; Corona R; Fucci M; Marzolini F; Rosmini F; Pasquini P
    Ann Ist Super Sanita; 1993; 29(3):469-72. PubMed ID: 8172468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
    Tas F; Kurul S; Camlica H; Topuz E
    Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
    Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
    Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.